Sort
78,016 grants matching “breast cancer”
Regulation of Neurotransmitter Action by Steroid Hormones in Females
$1,925,000Istvan Mody · University Of California Los Angeles · RF1 · FY2016 · AG
Signal Transduction of Paired Inhibitory Receptors of NK Cells and Macrophages
$1,924,963Daniel W. McVicar · Division Of Basic Sciences - Nci · ZIA · FY2019 · CA
Biostatistics and Data Management Core
$1,924,619Diana L Miglioretti · University Of California At Davis · P01 · FY2023 · CA
Studies of Occupational Cancer
$1,924,083Qing Lan · Division Of Cancer Epidemiology And Genetics · ZIA · FY2013 · CA
Epidemiology of putative genuine genetic variant: The Women's Health Intiative
$1,923,733Charles L Kooperberg · Fred Hutchinson Cancer Research Center · U01 · FY2008 · HG
Community Clinical Oncology Program
$1,923,566Shaker R Dakhil · Via Christi Regional Medical Center · U10 · FY2008 · CA
Environmental and Genetic Risk Factors For Breast Cancer: The Sister Study
$1,922,443Dale P Sandler · National Institute Of Environmental Health Sciences · ZIA · FY2024 · ES
Mechanisms of transcription pausing and fidelity in prokaryotes and eukaryotes
$1,921,593Mikhail Kashlev · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Genetic Modifiers of Cancer Risk
$1,920,922Lisa Mirabello · Division Of Cancer Epidemiology And Genetics · ZIA · FY2021 · CA
Infrastructure for Pathways, a Prospective Study of Breast Cancer Survivorship
$1,920,260Lawrence H Kushi · Kaiser Foundation Research Institute · U01 · FY2022 · CA
Genetic Variation in Cancer Risk and Outcomes in African Americans
$1,919,811Ann G Schwartz · Wayne State University · P01 · FY2024 · CA
Adapting MultiPLe behavior Interventions that eFfectively Improve (AMPLIFI) Cancer Survivor Health
$1,918,904Wendy Demark-Wahnefried · University Of Alabama At Birmingham · P01 · FY2018 · CA
Systems Analysis of Epigenomic Architecture in Cancer Progression
$1,918,884Tim H.-M. Huang · University Of Texas Hlth Science Center · U54 · FY2017 · CA
University of Arizona Cancer Prevention Clinical Trials Network (UA CP-CTNet)
$1,918,750H-H. Sherry Chow · University Of Arizona · UG1 · FY2021 · CA
University of Arizona Cancer Prevention Clinical Trials Network (UA CP-CTNet)
$1,918,750H-H. Sherry Chow · University Of Arizona · UG1 · FY2020 · CA
Understanding and preventing breast cancer disparties in Latinas
$1,918,546Beti Thompson · Fred Hutchinson Cancer Research Center · P50 · FY2010 · CA
BIOLOGICAL MARKERS OF BREAST CANCER &TAMOXIFEN RESPONSE
$1,917,538University Of Pennsylvania · P01 · FY2004 · CA
Breast Cancer Family Registry Cohort
$1,917,456Mary Beth Terry · Columbia University Health Sciences · U01 · FY2019 · CA
Epidemiology of putative genuine genetic variant: The Women's Health Intiative
$1,916,734Charles L Kooperberg · Fred Hutchinson Cancer Research Center · U01 · FY2010 · HG
PLCO Trial Etiologic and Early Marker Study
$1,915,866Robert Hoover · Division Of Cancer Epidemiology And Genetics · ZIA · FY2013 · CA
Effects of Public Information in Cancer (EPIC Center)
$1,913,763Robert C. Hornik · University Of Pennsylvania · P50 · FY2007 · CA
Data Production, and Informatics and Integration
$1,913,709Daniel A. Haber · Harvard Medical School · U54 · FY2011 · HG
The Biology of Lung Metastasis in Breast Cancer
$1,913,346Jonathan M. Backer · Albert Einstein College Of Medicine · P01 · FY2024 · CA
Improving the Clinical Effectiveness and Understanding of the Biophysical Basis
$1,912,533Theodore S Hong · Massachusetts General Hospital · U19 · FY2016 · CA
Epidemiology of putative genuine genetic variant: The Women's Health Intiative
$1,912,247Charles L Kooperberg · Fred Hutchinson Cancer Research Center · U01 · FY2011 · HG